D-Wave Quantum (QBTS) has gained just 0.6% since its second-quarter earnings report on August 6, significantly underperforming peers IonQ (IONQ) and Rigetti (RGTI) as well as the S&P 500.
Investors appear to be prioritizing near-term financial execution over D-Wave’s longer-term technology milestones, creating a visible disconnect between sentiment and strategic progress.
Second-quarter revenues came in essentially flat year over year and 19.5% below the Zacks Consensus Estimate, while adjusted EBITDA loss widened to $37.1 million.
Second-quarter bookings were only $2.1 million, a sharp drop from the $33.4 million recorded in the first quarter, highlighting the uneven demand patterns that continue to concern investors.
Despite that lumpiness, first-half bookings surged 1,120% to $35.5 million, and the company reported $40.7 million of remaining performance obligations, with 57% expected to convert within 12 months.
Two system deliveries are planned for 2026, and production applications already account for 37.3% of first-half quantum computing as a service revenues, offering potential near-term catalysts.
Stronger U.S. policy support for quantum commercialization and domestic supply chains continues to provide a favorable macroeconomic and regulatory backdrop for the sector.
The Zacks Consensus Estimate for third-quarter 2026 revenue stands at $3.95 million, a 5.7% improvement over the year-ago period, with a projected loss per share of 7 cents, narrower than the prior year’s 41-cent loss.
For full-year 2026, the Zacks Consensus Estimate for revenue is pegged at $38.63 million, representing a 57.1% improvement over the 2025 reported number, with projected EPS loss narrowing to 28 cents from $1.11 in 2025.
Those estimates place considerable weight on second-half execution, particularly the conversion of bookings, remaining performance obligations, and planned system deliveries into recognized revenue.
From a technical standpoint, QBTS trades below both its 50-day and 200-day simple moving averages, and the 50-day average remains below the 200-day average, offering no strong confirmation of a trend reversal.
Valuation remains a pressing concern, with QBTS trading at a 12-month price-to-sales ratio of 110.17x, compared with approximately 5x for the S&P 500 and well above its own three-year median P/S ratio of 87.89x.
That elevated multiple implies the stock already carries substantial growth expectations, leaving limited margin for any execution disappointments in the quarters ahead.
On the bullish side, the short-term average analyst price target of $35.79 implies 71.49% upside from the last close of $20.87, suggesting the market sees significant room for appreciation if commercial momentum holds.
Given the combination of strong pipeline potential and meaningful execution risks, QBTS currently carries a Zacks Rank of 3 (Hold), supporting a wait-and-watch approach until revenue conversion improves.
